What Is GHK-Cu?

GHK-Cu (Glycine-L-Histidine-L-Lysine copper complex) is a naturally occurring tripeptide-copper complex first isolated from human plasma albumin by Loren Pickart in 1973. Endogenous GHK levels decline dramatically with age — from approximately 200 ng/mL in young adults to below 80 ng/mL in those over 60. This age-related decline has been proposed as a contributor to the reduced wound healing capacity, collagen loss, and increased inflammation characteristic of aged tissue.

GHK-Cu research is unusually broad: Pickart’s original work has been followed by decades of independent research documenting effects across wound healing, hair follicle biology, anti-fibrotic mechanisms, antioxidant gene expression, and skin aging models. QSC stocks GHK-Cu at ≥99% HPLC with Janoshik COA. See also the BPC-157 + TB-500 + GHK-Cu triple repair blend for the most comprehensive repair stack available.

Why Copper Matters: GHK vs GHK-Cu

The copper (Cu²⁺) component of GHK-Cu is not a passive addition — it fundamentally changes the peptide’s behaviour. Cu²⁺ coordinates with the imidazole nitrogen of Histidine (position 2) and the alpha-amino group of Glycine (position 1), forming a stable square-planar copper chelate.

• Conformational change: Cu²⁺ coordination locks GHK into a compact, biologically active conformation. GHK alone adopts a more flexible, less receptor-active structure.
• Receptor affinity: The Cu²⁺-chelated form shows dramatically higher affinity for the cell-surface GHK-Cu receptor on fibroblasts and keratinocytes — the primary mediator of its ECM effects.
• Redox activity: Cu²⁺/Cu⁺ cycling by GHK-Cu activates superoxide dismutase (SOD)-like antioxidant chemistry, reducing local oxidative stress in wound environments.
• Copper delivery: GHK-Cu acts as a copper chaperone — delivering Cu²⁺ directly to copper-dependent enzymes including lysyl oxidase (LOX), which crosslinks collagen and elastin for mature ECM formation.

Mechanism 1: Collagen and ECM Gene Expression

The most documented GHK-Cu research effect is upregulation of collagen synthesis. Fibroblast exposure to GHK-Cu produces measurable increases in COL1A1 and COL1A2 gene expression (Type I collagen), as well as Type III and Type IV collagen — the major structural collagens of skin, tendon, and basement membrane, respectively. ^[1]

Beyond collagen, GHK-Cu upregulates a broader set of ECM components:

Mechanism 2: MMP Rebalancing

Matrix metalloproteinases (MMPs) are zinc-dependent proteases that degrade ECM components. In wound healing research, the MMP balance is critical: too little MMP activity leaves damaged ECM uncleared; too much degrades newly deposited collagen. GHK-Cu uniquely rebalances — rather than simply suppressing — MMP activity. ^[2]

• MMP-1 (collagenase): GHK-Cu reduces excessive MMP-1 in chronic wound models while preserving physiological MMP-1 for ECM turnover — a selective rather than blanket suppression.
• MMP-2 and MMP-9 (gelatinases): Reduced in fibrotic models, decreasing aberrant basement membrane degradation.
• TIMP-1 and TIMP-2 upregulation: GHK-Cu increases tissue inhibitors of metalloproteinases — the natural endogenous MMP regulators.

Mechanism 3: VEGF and FGF-Driven Angiogenesis

Adequate blood supply to healing tissue requires new capillary formation (angiogenesis). GHK-Cu stimulates both vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) — the two primary pro-angiogenic signalling molecules — in wound healing and skin explant models. ^[3]

This angiogenic mechanism partially overlaps with BPC-157 (VEGFR2 upregulation), but GHK-Cu acts upstream via growth factor secretion rather than directly on the receptor. The combination of GHK-Cu (VEGF/FGF upregulation) with BPC-157 (VEGFR2 sensitisation) is therefore studied as additive rather than redundant.

Mechanism 4: Anti-Inflammatory and Antioxidant Pathways

GHK-Cu shows significant anti-inflammatory activity in multiple models, via downregulation of NF-κB target genes and upregulation of antioxidant enzymes (SOD, catalase, metallothionein). A genomic analysis by Pickart (2008) identified GHK-Cu as a modulator of over 4,000 human genes — the majority related to tissue remodelling, inflammation control, and DNA repair. ^[4]

GHK-Cu in the Repair Blend Hierarchy

GHK-Cu occupies a distinct ECM layer in repair research that BPC-157 and TB-500 do not fully cover. Here is how the three primary repair peptides are stratified:

The BPC-157 + TB-500 + GHK-Cu triple repair blend represents the most complete non-overlapping repair mechanism combination available at QSC.

Purity and Copper Coordination Verification

GHK-Cu COA verification requires confirming both: (1) peptide sequence purity by HPLC (≥99%), and (2) copper coordination confirmed by MS — the GHK-Cu complex must show the expected m/z for the Cu²⁺-chelated form (~403.9 g/mol for the complex), not just free GHK (340.38 g/mol). QSC’s Janoshik COA covers both. Verify any batch at verify.janoshik.com.

Frequently Asked Questions

What is GHK-Cu and how does it work?

GHK-Cu (Glycine-L-Histidine-L-Lysine copper complex) is a naturally occurring copper tripeptide found in human plasma, urine, and saliva at concentrations that decline with age. It acts on extracellular matrix (ECM) remodelling by: (1) upregulating collagen synthesis (COL1A1, COL1A2 gene expression), (2) rebalancing matrix metalloproteinases (MMP-1, MMP-2, MMP-9), (3) stimulating VEGF and FGF for angiogenesis, and (4) activating anti-inflammatory and antioxidant pathways. Research use only.

What is the molecular weight of GHK-Cu?

The free tripeptide GHK (Glycine-Histidine-Lysine) has a molecular weight of 340.38 g/mol. The copper complex GHK-Cu adds Cu²⁺ coordination — effective MW approximately 403.9 g/mol for the complex. QSC stocks GHK-Cu at ≥99% HPLC with mass spectrometry confirmation via Janoshik independent COA (verify.janoshik.com).

Is GHK-Cu the same as GHK (without copper)?

GHK and GHK-Cu have the same tripeptide sequence (Gly-His-Lys) but different biological properties. The copper (Cu²⁺) component is not merely additive — Cu²⁺ coordinated into the His imidazole nitrogen and Lys amine changes the peptide’s conformation, dramatically increases its affinity for cell surface receptors, and is required for most of the documented ECM remodelling effects. GHK without copper is substantially less active in most wound healing research models.

Where can I buy GHK-Cu for research?

QSC (qsc-eu.com) stocks GHK-Cu at ≥99% HPLC purity with Janoshik independent COA publicly verifiable at verify.janoshik.com. Available individually and as part of the BPC-157 + TB-500 + GHK-Cu triple repair blend. Sold for in vitro laboratory research only — not for human consumption.

References

1. Pickart L et al. (2012). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. PMID 22510572.
2. Pickart L, Vasquez-Soltero JM, Margolina A. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Int J Mol Sci. PMID 25560772.
3. Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. PMID 24155859.
4. Pickart L. (1973). Human plasma fractions with growth-promoting activity on hepatoma cells. Ph.D. thesis, University of California.
5. Gorouhi F, Maibach HI. (2009). Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. PMID 23059136.
6. Google Search Central. Creating Helpful, Reliable, People-First Content. Updated December 2025.